Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_provenance.
- befree-20150227 importedOn "2015-02-27" NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_provenance.
- NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_assertion wasGeneratedBy ECO_0000203 NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_provenance.
- NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_assertion wasDerivedFrom befree-20150227 NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_provenance.
- NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_assertion SIO_000772 23470485 NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_provenance.
- NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_assertion evidence source_evidence_literature NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_provenance.
- NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_assertion description "[The selectivity of TRAIL towards cancer cells has promoted clinical evaluation of recombinant human TRAIL (rhTRAIL) and its agonistic antibodies in treating several major human cancers including colon and non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803940.RABLSlP3Sc1wtZ7QvdYt-bOJJyy1yHJanSSDxif1B2xow130_provenance.